Strides Arcolabs rise as its arm receives USFDA nod for Vinorelbine Injection

04 Sep 2012 Evaluate

Strides Arcolabs is currently trading at Rs. 824.00, up by 3.65 points or 0.44% from its previous closing of Rs. 820.35 on the BSE.

The scrip opened at Rs. 824.45 and has touched a high and low of Rs. 828.35 and Rs. 813.10 respectively. So far 20,000 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 868.00 on 24-Aug-2012 and a 52 week low of Rs. 279.05 on 13-Sep-2011.

Last one week high and low of the scrip stood at Rs. 857.35 and Rs. 813.10 respectively. The current market cap of the company is Rs. 4,828 crore.

The promoters holding in the company stood at 28.27% while Institutions and Non-Institutions held 54.03% and 17.70% respectively.

Strides Arcolab’s wholly owned subsidiary 'Onco Therapies', has received US Food and Drug Administration (USFDA) final approval for Abbreviated New Drug Application (ANDA) for Vinorelbine Injection USP, 10 mg/mL packaged in 10 mg/1 mL and 50 mg / 5mL single-dose vials.

Vinorelbine is part of the Oncology portfolio licensed to Pfizer for the US market and the product is available for immediate launch. Vinorelbine is used to treat various types of cancer. It is a chemotherapy drug that works by slowing or stopping cancer cell growth.

Strides Arcolab is a global pharmaceutical company headquartered in Bangalore, India that develops and manufactures wide range of IP-lead niche pharmaceutical products with an emphasis on sterile injectables.

Strides Pharma Scien Share Price

954.85 13.90 (1.48%)
03-Jul-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1531.05
Dr. Reddys Lab 6428.05
Cipla 1482.30
Zydus Lifesciences 1093.45
Lupin 1637.60
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.